StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Corporate ActionJun 22, 2026, 09:36 AM

SOPHiA GENETICS Closes $57.5M Public Offering, Underwriters Fully Exercise Option

AI Summary

SOPHiA GENETICS SA announced the closing of its previously announced underwritten public offering, generating total gross proceeds of $57.5 million. The company sold 12,104,900 ordinary shares at a price of $4.75 per share. The offering saw strong investor demand, leading to the underwriters fully exercising their option to purchase an additional 1,578,900 ordinary shares.

Key Highlights

  • Total gross proceeds from the offering were $57.5 million.
  • Company sold 12,104,900 ordinary shares.
  • Offering price per share was $4.75.
  • Underwriters fully exercised their option to purchase an additional 1,578,900 ordinary shares.
  • The offering closed on June 18, 2026.
  • TD Cowen acted as lead book-running manager.